Whether your project is large or small, we look forward to assisting you

About Us

Salupont Consulting was founded by Dr Daryl Rees and Dr Antonia Orsi to provide high quality, in depth product development consulting to both the pharmaceutical and food industries

Dr Daryl Rees

Clinical pharmacologist with over 25 years experience in R&D worldwide in small & large pharmaceutical & food companies for human & veterinary sectors

10 years experience as Executive Board Director of a public pharmaceutical & food innovation company (London Stock Exchange)

Proven expertise in successfully developing, commercialising & licensing pharmaceutical & food innovation products

Over 15 years experience and expertise as operational director of development activities including Quality, Non-clinical, Clinical, Regulatory & Intellectual Property activities

Expertise & experience as sponsor for clinical trials & coordinator of activities with global regulatory authorities & ethics committees

14 years experience as Chair of a UK Research Ethics Committee accredited for Phase I, II and III clinical trials, medical devices & tissue and genetic storage

Dr Antonia Orsi

British registered pharmacist & European/International registered toxicologist

Member of RQA and GxP auditor for European, US, Japanese and Chinese pharmaceutical and food companies

15 years experience in successful global medicines development and food innovation

Former Head of R&D of a public pharmaceutical and food innovation company

Achieved considerable success in identifying, pursuing and gaining scientific and financial support from charitable organisations

An experienced R&D scientist with a strong track record in successful product development within the pharmaceutical, healthcare and food innovation sectors

Chair of TOPRA in Italy (The Organisation for Professionals in Regulatory Affairs) with proven expertise in global regulations, training and technical aspects of the pharmaceutical and food industry

Particular expertise and experience in the design, implementation and evaluation of safety/toxicology studies of novel candidate medicines including complex mixtures

Our personable and professional team of consultants provide comprehensive knowledge in just about all aspects of product development